Established in 2019, Sonder Research X is a Weill Cornell Medical School spin-off company focused on using advanced imaging ...
Akeso Inc. (9926.HK) announced that its innovative, self-developed anti-PD-1 monoclonal antibody, penpulimab, has been officially approved by the National Medical Products Administration (NMPA) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback